Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Crinetics Pharmaceuticals (CRNX)
NASDAQ:CRNX
RESEARCH TOOLSreports
Crinetics Pharmaceuticals (CRNX) Stock Forecast & Price Target
438 Followers
See the Price Targets and Ratings of:
CRNX Analyst Ratings
Strong Buy
12 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
CRNX Stock 12 Month Forecast
Average Price Target
$69.33
▲(31.66% Upside)
| Highest Price Target$97.00 | Average Price Target$69.33 | Lowest Price Target$54.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Analyst Performance
Any
Analyst Rating
Any
Upside / Downside
Any
Action
Any
Piper Sandler
Assigned
07/17/24
J.P. Morgan
Reiterated
07/09/24
Oppenheimer
Reiterated
07/01/24
H.C. Wainwright
Reiterated
06/28/24
Morgan Stanley
Reiterated
06/04/24
JMP Securities
Reiterated
06/04/24
JonesTrading
Reiterated
06/04/24
LifeSci Capital
Reiterated
06/03/24
Leerink Partners
Reiterated
06/03/24
Citi
Reiterated
06/03/24
Robert W. Baird
$62
Buy
$62.00
(17.74% Upside)
Reiterated
06/03/24
Atumelnant: A Promising ACTH Antagonist in the CAH and Cushing's Syndrome Treatment Landscape
Cantor Fitzgerald
$65→$75
Buy
$75.00
(42.42% Upside)
Reiterated
05/22/24
Analysts Offer Insights on Healthcare Companies: Crinetics Pharmaceuticals (NASDAQ: CRNX) and BioMarin Pharmaceutical (NASDAQ: BMRN)
Evercore ISI
$51→$54
Buy
$54.00
(2.54% Upside)
Reiterated
02/12/24
Crinetics price target raised to $54 from $51 at Evercore ISICrinetics price target raised to $54 from $51 at Evercore ISI
Jefferies
$35
Hold
$35.00
(-33.54% Downside)
Initiated
12/20/23
Jefferies starts Crinetics (CRNX) at HoldJefferies initiates coverage on Crinetics (NASDAQ: CRNX) with a Hold rating and a price target of $35.00.
Best Analysts Covering Crinetics Pharmaceuticals
Which Analyst Should I Follow If I Want to Buy CRNX and Sell After:
1 Month
xxx
Success Rate
10/15 ratings generated profit
Average Return
+4.41%
assigned a xxx
rating 5 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 66.67% of your transactions generating a profit, with an average return of +4.41% per trade.
3 Months
xxx
Success Rate
10/11 ratings generated profit
Average Return
+23.08%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 90.91% of your transactions generating a profit, with an average return of +23.08% per trade.
1 Year
Success Rate
11/11 ratings generated profit
Average Return
+91.37%
reiterated a buy rating 2 months ago
Copying Brian Skorney's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +91.37% per trade.
2 Years
xxx
Success Rate
24/24 ratings generated profit
Average Return
+110.09%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +110.09% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
CRNX Analyst Recommendation Trends
Rating
Feb 24
Mar 24
May 24
Jun 24
Jul 24
Strong Buy
7
7
12
14
13
Buy
19
27
33
33
20
Hold
1
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
27
34
45
47
33
Each month's total comprises the sum of three months' worth of ratings.
CRNX Financial Forecast
CRNX Stock Forecast FAQ
What is CRNX’s average 12-month price target, according to analysts?
Based on analyst ratings, Crinetics Pharmaceuticals’s 12-month average price target is $69.33.
What is CRNX’s upside potential, based on the analysts’ average price target?
Crinetics Pharmaceuticals has 31.66% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is CRNX a Buy, Sell or Hold?
Crinetics Pharmaceuticals has a consensus rating of Strong Buy which is based on 12 buy ratings, 0 hold ratings and 0 sell ratings.
What is Crinetics Pharmaceuticals’s price target?
The average price target for Crinetics Pharmaceuticals is $69.33. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $97.00 ,the lowest forecast is $54.00. The average price target represents 31.66% Increase from the current price of $52.66.
The highest analyst price target is $97.00 ,the lowest forecast is $54.00. The average price target represents 31.66% Increase from the current price of $52.66.
What do analysts say about Crinetics Pharmaceuticals?
Crinetics Pharmaceuticals’s analyst rating consensus is a Strong Buy. This is based on the ratings of 12 Wall Streets Analysts.
How can I buy shares of CRNX?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.